Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Hospital Authority, Hong Kong |
---|---|
Information provided by: | Hospital Authority, Hong Kong |
ClinicalTrials.gov Identifier: | NCT00563485 |
The purpose of the study is to compare two alpha blockers, terazosin and doxazosin GITS, in achieving a successful TWOC after AUR due to BPH, among Chinese males in Hong Kong, and in delaying or avoiding a TURP.
Condition | Intervention |
---|---|
Prostatic Hyperplasia Urinary Retention |
Drug: Doxazosin GITS (Cardura XL) Drug: Terazosin (Hytrin) |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Placebo Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily in the Successful Rate of Trial Without Catheter in Acute Urinary Retention With Long Term Follow up |
Estimated Enrollment: | 120 |
Study Start Date: | October 2005 |
Study Completion Date: | November 2006 |
Ages Eligible for Study: | 50 Years and older |
Genders Eligible for Study: | Male |
Inclusion Criteria:
Exclusion Criteria:
China | |
Prince of Wales Hospital | |
Hong Kong, China |
Principal Investigator: | Chi Wai Cheng, Dr | Department of Surgery, Division of Urology, North District Hospital/ The Chinese University of Hong Kong |
Study ID Numbers: | CRE-2005.313-T, HARECCTR0500049 |
Study First Received: | November 21, 2007 |
Last Updated: | June 23, 2009 |
ClinicalTrials.gov Identifier: | NCT00563485 History of Changes |
Health Authority: | Hong Kong: Ethics Committee |
Benign Prostatic Hyperplasia (BPH) Acute Retention of Urine (AUR) |
Neurotransmitter Agents Prostatic Diseases Adrenergic Agents Urination Disorders Cardiovascular Agents Adrenergic alpha-Antagonists Antihypertensive Agents Urinary Retention |
Genital Diseases, Male Doxazosin Terazosine Hyperplasia Prostatic Hyperplasia Urologic Diseases Adrenergic Antagonists |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Prostatic Diseases Adrenergic Agents Urination Disorders Physiological Effects of Drugs Cardiovascular Agents Adrenergic alpha-Antagonists Antihypertensive Agents Urinary Retention |
Genital Diseases, Male Pharmacologic Actions Terazosine Doxazosin Hyperplasia Pathologic Processes Prostatic Hyperplasia Urologic Diseases Therapeutic Uses Adrenergic Antagonists |